Roche · 2 hours ago
2026 Summer Intern - Sequencing Hardware Development
Roche is a global healthcare company dedicated to advancing science and providing access to healthcare. They are seeking a Summer Intern in Sequencing Hardware Development to gain hands-on experience in system development through various activities including characterization, investigation, integration, and verification.
BiotechnologyHealth CareHealth DiagnosticsOncologyPharmaceuticalPrecision Medicine
Responsibilities
The intern role will give you hands-on experience with system development by participating in characterization, investigation, integration, and verification activities
Qualification
Required
Must be pursuing a Bachelor's Degree (enrolled student)
Must have attained a Bachelor's Degree (not currently enrolled in a graduate program)
Required Majors: Mechanical Engineering, Electrical Engineering, Biomedical Engineering, Bioengineering, Systems Engineering
Preferred
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Experience in developing test methods
Experience with characterization studies
Familiarity with JMP, MATLAB, or other statistical analysis software
Benefits
Paid holiday time off benefits
Company
Roche
Roche is a pharmaceutical and diagnostics company that offers medicines and diagnostic tests for various medical conditions and diseases.
H1B Sponsorship
Roche has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (9)
2023 (6)
2022 (2)
2021 (2)
Funding
Current Stage
Public CompanyTotal Funding
$7.79BKey Investors
SoftBankSCALE AINovartis
2021-08-04Post Ipo Equity· $5B
2020-12-07IPO
2020-05-06Post Ipo Equity· $0.5M
Leadership Team
Recent News
2026-01-25
2026-01-23
2026-01-22
Company data provided by crunchbase